collection
MENU ▼
Read by QxMD icon Read
search

YUEJN-DEB&DES

shared collection
5 papers 0 to 25 followers
By Jianing Yue Attending Vascular Surgeon, Zhongshan Hospital Fudan University, Shanghai, China
https://www.readbyqxmd.com/read/27151609/1-year-results-of-paclitaxel-coated-balloons-for-long-femoropopliteal-artery%C3%A2-disease-evidence-from-the-sfa-long-study
#1
Antonio Micari, Giuseppe Vadalà, Fausto Castriota, Armando Liso, Chiara Grattoni, Paolo Russo, Alfredo Marchese, Paolo Pantaleo, Giuseppe Roscitano, Bruno Mario Cesana, Alberto Cremonesi
OBJECTIVES: The aim of this study was to appraise 1-year outcomes after percutaneous treatment of long femoropopliteal artery disease using paclitaxel-coated balloons. BACKGROUND: Percutaneous transluminal angioplasty with paclitaxel-coated balloons for TransAtlantic Inter-Society Consensus types A and B femoropopliteal artery disease has provided favorable results. METHODS: Consecutive patients with Rutherford class 2 to 4 disease due to femoropopliteal lesions >15 cm long and with 4- to 7-mm reference vessel diameter were prospectively enrolled in a multicenter study...
May 9, 2016: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/26511896/paclitaxel-eluting-balloon-vs-standard-angioplasty-to-reduce-restenosis-in-diabetic-patients-with-in-stent-restenosis-of-the-superficial-femoral-and-proximal-popliteal-arteries-three-year-results-of-the-debate-isr-study
#2
Simone Grotti, Francesco Liistro, Paolo Angioli, Kenneth Ducci, Giovanni Falsini, Italo Porto, Lucia Ricci, Giorgio Ventoruzzo, Filippo Turini, Guido Bellandi, Leonardo Bolognese
PURPOSE: To report the 3-year safety and effectiveness outcomes from the prospective all-comers DEBATE-ISR study (ClinicalTrials.gov identifier NCT01558531) of symptomatic diabetic patients with femoropopliteal in-stent restenosis (ISR) undergoing treatment with paclitaxel-eluting balloons compared with historical diabetic controls. METHODS: From January 2010 to December 2011, 44 consecutive diabetic patients (mean age 74±11 years; 32 men) were treated with drug-eluting balloons (DEBs) and enrolled in the study...
February 2016: Journal of Endovascular Therapy
https://www.readbyqxmd.com/read/23581752/meta-analysis-of-outcomes-of-endovascular-treatment-of-infrapopliteal-occlusive-disease-with-drug-eluting-stents
#3
REVIEW
George A Antoniou, Nicholas Chalmers, Kavitha Kanesalingham, Stavros A Antoniou, Andrew Schiro, Ferdinand Serracino-Inglott, John Vincent Smyth, David Murray
PURPOSE: To review emerging evidence regarding the use of bare metal (BMS) vs. drug-eluting stents (DES) in the treatment of infrapopliteal occlusive disease. METHODS: A systematic review of the literature was undertaken to identify all studies comparing stent treatments of infragenicular vessels in patients with chronic lower limb ischemia. Validated methods to assess the methodological quality of the included studies were applied. Outcome data were pooled, and combined overall effect sizes were calculated using fixed or random effects models...
April 2013: Journal of Endovascular Therapy
https://www.readbyqxmd.com/read/23517840/2-year-results-of-paclitaxel-eluting-balloons-for-femoropopliteal-artery-disease-evidence-from-a-multicenter-registry
#4
MULTICENTER STUDY
Antonio Micari, Angelo Cioppa, Giuseppe Vadalà, Fausto Castriota, Armando Liso, Alfredo Marchese, Chiara Grattoni, Paolo Pantaleo, Alberto Cremonesi, Paolo Rubino, Giancarlo Biamino
OBJECTIVES: This study aimed to appraise 2-year outcomes after percutaneous treatment of femoropopliteal artery disease with paclitaxel-eluting balloons. BACKGROUND: Percutaneous transluminal angioplasty with paclitaxel-eluting balloons for femoropopliteal artery disease has provided favorable 1-year results. METHODS: Consecutive patients with Rutherford class 2 to 4 disease due to femoropopliteal lesions ≤15 mm long and with 3- to 7-mm reference vessel diameter were prospectively enrolled in a multicenter registry...
March 2013: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/23517839/treatment-of-femoropopliteal-in-stent-restenosis-with-paclitaxel-eluting-stents
#5
MULTICENTER STUDY
Thomas Zeller, Michael D Dake, Gunnar Tepe, Klaus Brechtel, Elias Noory, Ulrich Beschorner, Patricia L Kultgen, Aljoscha Rastan
OBJECTIVES: This study sought to evaluate the outcomes of drug-eluting stent treatment for femoropopliteal in-stent restenosis (ISR). BACKGROUND: ISR after femoropopliteal interventions is an increasing problem. Although the role of drug-eluting stents in the treatment of coronary ISR is well defined, no published studies have examined drug-eluting stents in the treatment of femoropopliteal ISR. METHODS: This study examines 108 patients with 119 ISR lesions who were enrolled in the ZILVER-PTX single-arm study, a prospective, multicenter clinical trial of 787 patients...
March 2013: JACC. Cardiovascular Interventions
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"